Madhya Bharat Agro Products Q4 FY26: PAT Up 163%, Debt Explodes to ₹856 Cr, Dhule Expansion Could Change Everything
1. At a Glance
There are fertilizer companies. Then there are fertilizer companies that suddenly decide they want to become an industrial empire.
Madhya Bharat Agro Products Ltd has spent FY26 behaving less like a mid-sized fertilizer player and more like a man who has watched too many motivational videos on YouTube at 2 AM.
Revenue jumped to ₹1,867 crore in FY26 from ₹1,058 crore in FY25. PAT rose from ₹57 crore to ₹150 crore. EPS moved from ₹6.56 to ₹17.14. Return on equity sits at an eye-catching 31.5%.
And yet, despite all this, the stock still manages to look confusing.
Why?
Because alongside that profit growth, borrowings exploded from ₹318 crore to ₹856 crore in just one year. Total liabilities ballooned to ₹1,682 crore. Free cash flow crashed to negative ₹524 crore. Cash from operations turned negative ₹127 crore in FY26.
So what exactly is happening here?
Simple.
The company is throwing money into a massive fertilizer and chemical expansion cycle. Dhule in Maharashtra is the big bet. New DAP/NPK, SSP, sulphuric acid and phosphoric acid capacities are being added. Management believes that after these expansions, the company could become one of the largest phosphatic fertilizer players in India.
That is the exciting part.
The scary part is that this growth is coming with leverage, working capital dependence, subsidy receivables and exposure to raw material imports from politically unstable regions.
One side of the story says this is an early-stage compounder building a moat.
The other side says this is a fertilizer company running at 115% utilization while borrowing heavily and praying that government subsidy payments arrive on time.
Both sides are true.
That is what makes Madhya Bharat Agro Products interesting.
2. Introduction
Madhya Bharat Agro Products is part of the Ostwal Group and is focused on phosphatic fertilizers.
Its brands are not glamorous. Nobody is showing off bags of SSP on Instagram. But in India, fertilizer is serious business.
The company manufactures SSP, DAP/NPK fertilizers, sulphuric acid, phosphoric acid and beneficiated rock phosphate.
This is important because India imports a large chunk of its phosphatic fertilizer requirement. That means companies with local manufacturing, backward integration and raw material access have a structural advantage.
MBAPL has spent the last few years building exactly that.
It already has a rock phosphate beneficiation plant. It produces sulphuric acid and phosphoric acid in-house. It has long-term raw material agreements. It has over 2,500 wholesalers, 30,000 retailers and 150+ marketing professionals.
That is not a small network.
The company’s biggest strength is that it is not just selling fertilizer. It is building a vertically integrated fertilizer chain.
But fertilizer businesses are never simple.
Margins depend on subsidy rates, raw material prices, government policies, weather, monsoon, crop patterns, import competition and whether ammonia prices decide to behave like Bitcoin.
The company had a blockbuster FY26. But investors now need to ask a harder question.
Can the business maintain profitability while handling massive capex, higher debt and rising working capital?
Because fertilizer companies can go from “future industry leader” to “please refinance our loans” very quickly.
3. Business Model – WTF Do They Even Do?
Madhya Bharat Agro Products mainly makes phosphatic fertilizers.
Its biggest products are:
SSP (Single Super Phosphate)
DAP/NPK fertilizers
Sulphuric acid
Phosphoric acid
Beneficiated rock phosphate
Think of SSP as the old-school fertilizer. DAP/NPK is the more premium, more balanced fertilizer product where demand is growing.
Currently, the company has:
SSP capacity of 240,000 MTPA
DAP/NPK capacity of 240,000 MTPA
Sulphuric acid capacity of 165,000 MTPA
Phosphoric acid capacity of 49,500 MTPA
BRP capacity of 189,000 MTPA
Now comes the crazy part.
The company is expanding almost everything.
DAP/NPK capacity is expected to rise to 570,000 MTPA. Sulphuric acid capacity is going from 165,000 MTPA to 363,000 MTPA. Phosphoric acid capacity is expected to jump sharply too.
Management says Dhule alone could add over ₹2,000 crore of revenue once fully operational.
That is huge for a company that just reported ₹1,867 crore revenue for FY26.
The company is also using imports strategically.
Management admitted that imported fertilizers are low-margin products, but they help build presence in South India and offer a wider range of NPK variants. It is basically market seeding.
This is smart.
You enter the market through imports, build dealer relationships, then later push your own manufactured products once your plant is ready.
Very classic “first get invited to the wedding, then bring your own catering business” strategy.
4. Financials Overview
Since the latest official heading is Quarterly Results, FY26 Q4 EPS annualisation is not required because full-year FY26 EPS is already available.
Metric
Latest Quarter Mar 2026
Same Quarter Last Year Mar 2025
Previous Quarter Dec 2025
Revenue
₹395 Cr
₹297 Cr
₹612 Cr
EBITDA
₹41 Cr
₹36 Cr
₹66 Cr
PAT
₹60 Cr
₹14 Cr
₹32 Cr
EPS
₹6.82
₹1.63
₹3.62
Q4 FY26 was bizarre in a good way.
Revenue actually fell sequentially from ₹612 crore in Q3 to ₹395 crore in Q4. But PAT jumped from ₹32 crore to ₹60 crore.
That happened because tax reversed sharply. The company reported a negative tax rate in Q4, which boosted profitability.
So yes, the quarter looked fantastic.
But investors should remember that Q4 PAT is not fully clean because of the tax benefit.
For the full year, revenue grew 76.5% and PAT grew 161%.
That is monster growth.
5. Valuation Discussion – Fair Value Range Only
Current market price is around ₹510.
FY26 EPS is ₹17.14.
P/E Method
At 18x P/E:
Fair value = ₹308
At 24x P/E:
Fair value = ₹411
At 30x P/E:
Fair value = ₹514
EV/EBITDA Method
Enterprise value is ₹5,296 crore.
FY26 EBITDA is roughly operating profit plus depreciation = ₹227 crore + ₹37 crore = around ₹264 crore.
Current EV/EBITDA is about 20x.
A reasonable range could be 14x–18x EBITDA.
That gives an implied valuation range of roughly ₹3,696 crore to ₹4,752 crore enterprise value.
After adjusting for debt, equity value range comes roughly to ₹2,840 crore to ₹3,896 crore.
That translates to approximately ₹325 to ₹445 per share.
DCF Style Thought Process
If revenue can indeed rise 50%+ in FY27 and Dhule ramps up smoothly, the market may continue assigning a premium multiple.
But if margins compress and debt rises too fast, the stock can de-rate quickly.
Overall fair value range appears to be around ₹325–₹515 per share.
This fair value range is for educational purposes only and is not investment advice.
